Benefits
Growth (anagen) phase of hair follicles
In a 90-day randomized placebo-controlled trial, 100 healthy adults took a once-daily spermidine-based tablet. The share of hair follicles in the active growth (anagen) phase rose, with a higher cell-proliferation marker and a lower apoptosis marker in the hair bulb, and a negative hair pull test. This was a small, maker-funded study of a spermidine-based blend rather than pure spermidine, so it needs confirmation.
Memory in older adults with subjective cognitive decline
A 12-month randomized placebo-controlled trial in 100 older adults with subjective cognitive decline used a wheat germ extract giving 0.9 mg spermidine a day. It found no change in the main memory measure or in biomarkers versus placebo, with only exploratory hints on verbal memory and inflammation. An earlier 3-month pilot had suggested a memory gain that this larger, longer trial did not confirm.
Immune cell function and vaccine antibody response in older adults
In a 13-week randomized placebo-controlled pilot, 40 adults over 65 took 6 mg of spermidine a day after a COVID-19 vaccine dose. Among people who had responded poorly to the vaccine, markers of immune-cell aging improved and spike-specific antibody and memory B-cell responses rose. This is one small pilot using laboratory immune measures, not evidence of fewer infections, and it has not been repeated.
Autophagy, the cell's protein and organelle recycling process
Spermidine is needed to modify the protein eIF5A (a step called hypusination) that cell and animal studies link to switching on autophagy, the housekeeping process that clears damaged proteins and worn-out organelles. These findings come from laboratory and animal work. Studies that actually measure autophagy in people taking spermidine are few and used other products.
Mechanism of action
Switches on autophagy through eIF5A
Spermidine is the unique substrate for hypusination of the translation factor eIF5A, a modification that cell and animal studies show is needed to make several autophagy-related proteins. Through this route spermidine can increase autophagy in laboratory models. This is distinct from how other autophagy inducers act, and it has not been demonstrated in people taking a supplement.
Broken down and tightly regulated in the body
Swallowed spermidine is partly broken down in the gut, and the body keeps polyamine levels within a narrow range. In controlled trials, 15 mg a day for 5 days and 40 mg a day for 28 days did not meaningfully raise blood spermidine, which is why benefits are expected to build slowly if at all and why the right dose is uncertain.
Tissue levels tend to fall with age
Some studies report that spermidine levels in blood and tissues are lower in older people. This observation is the rationale offered for supplementing, but a causal role in human aging has not been established, and restoring blood levels with a supplement has proved difficult.
Clinical trials
Randomized, double-blind, placebo-controlled trial of a once-daily spermidine-based nutritional supplement for 90 days, with plucked-follicle and immunohistochemistry endpoints (Rinaldi et al. 2017, Dermatol Pract Concept)
100 healthy men and women; spermidine-based tablet or placebo once daily for 90 days.
The number of follicles in the active growth (anagen V-VI) phase rose after 3 months, with higher Ki-67 (proliferation) and lower c-Kit (apoptosis) in the hair bulb, all better than placebo. The hair pull test stayed negative in all supplement users at 6 months versus 68% positive on placebo. The authors call it preliminary; the product is a spermidine-based blend and three authors were employed by or consulted for the maker.
12-month randomized, double-blind, placebo-controlled phase 2b trial of a wheat germ extract giving 0.9 mg spermidine a day for memory (Schwarz et al. 2022, JAMA Netw Open)
100 adults aged 60 to 90 with subjective cognitive decline (51 spermidine, 49 placebo); 89 completed.
The primary memory outcome did not differ from placebo (between-group difference -0.03, 95% CI -0.11 to 0.05, P = .47), and secondary outcomes and biomarkers were unchanged. Exploratory analyses hinted at possible effects on verbal memory and inflammation that the authors said need testing at higher doses. Adverse events were balanced. Several authors held equity in the extract's maker.
3-month randomized, double-blind, placebo-controlled phase 2a pilot of a wheat germ extract giving about 1.2 mg spermidine a day (Wirth et al. 2018, Cortex)
30 cognitively healthy older adults aged 60 to 80 with subjective cognitive decline.
Memory scores were higher than placebo at 3 months by effect size, but the result was imprecise in a 30-person pilot and the between-group estimate reached toward no difference. The larger 12-month SmartAge trial that followed found no memory benefit, so this early signal was not confirmed.
Double-blind, randomized, placebo-controlled pilot of 6 mg oral spermidine a day for 13 weeks after a third SARS-CoV-2 vaccine dose (Alsaleh et al. 2026, Aging Cell)
40 adults over 65 years of age.
Supplementation was well tolerated. Among people who had responded poorly to the vaccine, spermidine lowered markers of immune-cell aging and raised spike-specific IgG, memory B-cell recall and neutralising antibody activity; autophagy-related genes rose in B cells. A single small pilot with laboratory immune endpoints and no clinical infection outcome.
Exploratory double-blind, within-subject, placebo-controlled trial of a high-purity spermidine supplement at 40 mg a day for up to 28 days (Keohane et al. 2024, Nutr Res)
37 healthy men aged 50 to 70.
At 40 mg a day there were no significant changes in clinical, lipid, chemistry or blood-count safety measures and no product-related adverse events. Serum and urine polyamine levels did not rise substantially, which the authors read as effective homeostatic control. The study assessed safety only; the maker funded it.
Randomized, placebo-controlled crossover pharmacokinetic and metabolomic study of 15 mg spermidine a day from a chlorella and soybean supplement for 5 days (Senekowitsch et al. 2023, Nutrients)
12 healthy adults.
Compared with placebo, 15 mg a day of spermidine raised plasma spermine but not plasma or salivary spermidine over 5 days. The authors concluded that spermidine supplements below 15 mg a day are unlikely to have short-term effects on blood spermidine.
Prospective population cohort relating dietary spermidine intake from food questionnaires to mortality; no supplement was given (Kiechl et al. 2018, Am J Clin Nutr)
829 adults aged 45 to 84 in Bruneck, Italy, followed for 20 years (341 deaths).
People with higher dietary spermidine intake had lower all-cause mortality (adjusted hazard ratio 0.76 per 1-SD higher intake), replicated in a second cohort. This is an observational diet association: high-spermidine diets are also rich in vegetables, whole grains and legumes, so it reflects an overall diet pattern and cannot show that a supplement extends life.